Evaluation of pharmacokinetic interactions between long‐acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084

Abstract Introduction HPTN 084 found that long‐acting cabotegravir (CAB‐LA) was well‐tolerated and significantly reduced the risk of HIV acquisition in women compared to tenofovir disoproxil fumarate/emtricitabine (F/TDF). During the blinded phase of the trial, participants were required to use an e...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Mark A. Marzinke, Brett Hanscom, Daniel Haines, Kimberly K. Scarsi, Yaw Agyei, Estelle Piwowar‐Manning, Craig W. Hendrix, Ryann Gollings, Scott Rose, Carrie Mathew, Ravindre Panchia, Elizabeth Spooner, Nishanta Singh, Peter Bock, Alex R. Rinehart, Susan L. Ford, James F. Rooney, Lydia Soto‐Torres, Myron S. Cohen, Mina C. Hosseinipour, Sinead Delany‐Moretlwe, HPTN 084 Study Team
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Wiley 2025-11-01
Serie:	Journal of the International AIDS Society
Ämnen:	cabotegravir contraception HIV prevention long‐acting PrEP women
Länkar:	https://doi.org/10.1002/jia2.70056
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!